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ABSTRACT 
Risk analysis and population health management can improve health outcomes, 
but improved risk stratification is needed to manage healthcare costs. Analysis of 157 
publications on translational implementations of “risk stratification in population health 
management of chronic disease” showed a consensus that population health management 
and risk stratification can improve outcomes, but found uncertainty over best methods for 
risk prediction and controversy over the cost savings. The consensus of another 85 
publications on the methodologies of “data mining for predictive healthcare analytics” 
was that clinically interpretable machine learning techniques are more appropriate than 
“black box” techniques for structured big data sources in healthcare, and the “area under 
the curve” of a prediction model’s sensitivity versus one-minus-specificity is a standard 
and reliable way to measure the model’s discrimination. This study used clinically 
interpretable machine-learning algorithms, combined with simple but powerful data 
analytic techniques such as cost analysis and data visualization, to evaluate and improve 
risk stratification for a managed patient population. 
 This study retrospectively observed 10,000 mid-Missouri Medicare and Medicaid 
patients between 2012 and 2014. Cost and utilization analyses, statistical clustering, 
contrast mining, and logistic regression were used to identify patients within a managed 
population at risk for higher healthcare costs, demonstrate longitudinal changes in risk 
stratification, and characterize detailed differences between high-risk and low-risk 
patients. The two highest risk stratification tiers comprised only 21% of patients but 
accounted for 43% of prospective charges. Patients in the most expensive sub-cluster of 
the most expensive risk tier were nearly twice as costly as high-risk patients on average. 
ix 
 
Combining contrast mining with logistic regression predicted the most expensive 5% of 
patients with 84% accuracy, as measured by area under the curve. 
All the strategies used in this study, from the simplest to the most sophisticated, 
produced useful insights. By predicting the small number of patients who will incur the 
majority of healthcare expenses in terms that are clinically interpretable, these methods 
can support population health managers in focusing preventive and longitudinal care 
more effectively. These models, and similar models developed by integrating diverse 
informatics strategies, could improve health outcomes, delivery, and costs.  
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CHAPTER 1.  INTRODUCTION 
 
1.1 Nature and purpose of the study 
The Chronic Care Model (Wagner et al., 2001) proposed improving the 
effectiveness of interactions between patients and providers as a way of promoting the 
“Triple Aim” of healthcare (Berwick, Nolan, & Whittington, 2008): (a) better health, (b) 
better care, and (c) lower costs (Glasgow, Orleans, & Wagner, 2001). These positive 
outcomes may be anticipated on the basis of improved interactions between informed, 
activated patients and prepared, proactive providers (Wagner et al., 2001). Evidence also 
has shown that patients with care coordinators have fewer emergency department and 
urgent care episodes (Kruse, Zweig, et al., 2010), hospital admissions (Sanderson & 
Dixon, 2000), and readmissions (Verhaegh et al., 2014). 
Care coordination is “… the deliberate organization of patient care activities 
between two or more participants (including the patient) involved in the patient’s care to 
facilitate the appropriate delivery of health service…” (McDonald, Vickers, Mohan, 
Wilkes, & Jackson, 2010). Care coordination is increasingly being used across the 
healthcare system to improve patient outcomes for populations of patients and is a core 
element of both the Triple Aim and the Chronic Care Model. In order for care 
coordinators to manage populations of patients, they must be able to identify the patients 
who are most in need of their services; one approach to this challenge is risk 
stratification. Indeed, risk stratification is crucial for effective population health 
management because it provides care coordinators the opportunity to focus their work on 
those patients who will benefit the most (McCusker et al., 1999; Suijker, et al., 2012; van 
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Walraven et al., 2010). Risk stratification is a potentially powerful tool for predicting 
population health outcomes, and previous healthcare utilization has been shown to be a 
useful predictor of future healthcare needs (Wherry, Burns, & Leininger, 2014).  
However, most predictive indices for health outcomes in community-dwelling 
adults have less than 70 percent accuracy (O’Caoimha et al., 2015) and relatively few 
attempts have been made to stratify entire primary care populations. The present study 
attempts to categorize and predict high-risk members of a managed patient population, 
using informatics strategies that are simpler, more comprehensive, and more accurate. 
This introductory chapter will briefly outline the significance of care coordination and the 
innovation represented by these approaches, and set our three specific aims for their 
implementation. 
 
1.2 Significance of the study 
US healthcare costs continue to rise faster than inflation (Forbes.com LLC, 2015). 
Figure 1 shows how this “cost curve” continues to rise faster than the US gross domestic 
product (GDP) and consume more of the US federal budget, putting the long-term 
solvency of the program at risk (US Centers for Medicare & Medicaid Services, 2013). 
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Figure 1. Actual and Projected Net Medicare Spending, 2010-2026 
 
(Cubanski & Neuman, 2016) 
 
Half of health care expenses in the United States are incurred by five percent of 
the population (Cohen & Uberoi, 2013; Stanton & Rutherford, 2005), and 86% of US 
healthcare resources are consumed in managing chronic diseases (Bodenheimer, Wagner, 
& Grumbach, 2002; Gerteis, Izrael, Deitz, LeRoy, & Ricciardi, 2014). In order to reduce 
the public and private burdens of paying for healthcare without reducing quality or 
access, care delivery must be made more efficient, proactive, and effective (US 
Congressional Budget Office, 2013). 
 To achieve the “Triple Aim” of (a) better health outcomes, (b) better health care 
delivery, and (c) lower costs (Berwick, Nolan, & Whittington, 2008), the Chronic Care 
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Model seeks to improve interactions between informed, activated patients and prepared, 
proactive providers (Wagner et al., 2001), including proactive and preventive care 
(Glasgow, Orleans, & Wagner, 2001). Unfortunately, health care often fails to provide 
effective coordination of care across a target population (Bodenheimer, Wagner, & 
Grumbach, 2002; Coleman, Austin, Brach, & Wagner, 2009). When care coordinators 
don’t know which of their patients are at greatest risk for worsening outcomes, they 
allocate their time by responding to the patient in front of them at the moment 
(Snyderman & Williams, 2003).  
 In contrast to less predictable causes of poor health such as traumatic injury, the 
presence of pre-existing chronic conditions situates patients ideally for proactive 
intervention, and population health managers are ideally situated to deliver that 
preventive care if they can focus their work efficiently (Bates, Saria, Ohno-Machado, 
Shah, & Escobar, 2014). This supports the transition from the traditional “reactive” 
model of medical care (Snyderman & Williams, 2003) to one of maintaining health and 
avoiding preventable conditions, and accomplishing the Triple Aim (Amarasingham, 
Patzer, Huesch, Nguyen, & Xie, 2014). Accomplishing the Triple Aim promises to not 
only improve health outcomes for healthcare consumers, but improve financial outcomes 
for those who pay directly or indirectly for healthcare – including everyone who pays 
taxes, has health insurance, or has a job, savings, or investments. 
 
1.3 Innovative informatics strategies and applications 
The number of clinical prediction rules published every decade is expanding at an 
accelerating rate (Keogh et al., 2014). Electronic health care predictive analytics built on 
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these clinical predictors can be used to rapidly spot hard-to-identify opportunities to 
better manage care (Bradley, 2012), but previous predictive analytics based on statistical 
analysis have had limited usefulness (Kansagara et al., 2011). Part of the reason for this 
may be limitations in the mathematical tools used to construct the models, because 
regression analysis and other traditional statistical methods are constrained by the limited 
number of features that can be used (Kantardzic, 2003). In order to limit the number of 
model features deductively – that is, before attempting to build and validate a model – 
some predictive algorithms have focused on specific conditions such as diabetes (Khalid 
et al., 2014) or hypertension (Sun et al, 2014). 
 Other predictive analytics have built successful models on demographic and 
utilization characteristics with only high-level summaries of clinical data (Chechulin, 
Nazerian, Rais, & Malikov, 2014). However, this strategy fails to exploit the highly 
detailed clinical history available in electronic medical records (EMR). Data mining 
algorithms would permit models that surpass these size limits and could leverage the rich 
data available in the EMR (Witten & Frank, 2005). Advanced informatics strategies, 
including cluster analysis and data-mining algorithms, are likely to be more appropriate 
to applying high-dimensional data to this complex problem (He, Mathews, Kalloo, & 
Huftless, 2014), particularly when designed to produce clinically interpretable results 
(Fraccaro et al., 2015). 
 
1.4 Objectives of the study 
This study tests the hypothesis that clinically interpretable machine-learning 
algorithms, combined with simpler data analytic techniques where appropriate, can 
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improve risk stratification in population health management of chronic disease. Three 
specific aims arise from the application of these innovative informatics strategies to risk 
stratification in chronic disease management:  
1. Develop and validate a reproducible system of identifying patients within a 
managed population who are at increased risk for higher healthcare costs 
2. Demonstrate the longitudinal changes in risk stratification within a cohort of 
well insured primary care patients 
3. Characterize the differences between patients at higher and lower risks of 
increased healthcare utilization and costs in clinically useful terms 
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CHAPTER 2.  LITERATURE REVIEW 
 
2.1 Topics for review 
In order to discover the research literature relevant to both the translational and 
methodological aspects of this study, two searches were conducted. The first literature 
review focused on the topic of “risk stratification in population health management of 
chronic disease” and the second one focused on the topic of “data mining for predictive 
healthcare analytics”.  
 
2.2 Methodology of the literature review 
The first literature review, on the topic of “risk stratification in population health 
management of chronic disease,” searched two databases of medical evidence, 
MEDLINE and CINAHL. These two databases were selected as the most widely 
accepted resources for searching the literatures of medicine and nursing (Brazier & 
Begley, 1996). 
For MEDLINE, which uses the MeSH system of subject headings, the search used 
this query: 
 
((risk assessment[MeSH term])  
AND managed care[MeSH term]) 
 AND chronic disease[MeSH term] 
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while for CINAHL, which has an expanded set of subject headings including terms closer 
to the defined search topic, the search used this query: 
 
SU risk stratification  
AND SU population health management  
AND SU chronic disease  
 
(where SU = subject) in CINAHL’s SmartText Searching search mode. Both searches 
were limited to publications in the English language and to research articles. CINAHL 
was further restricted to peer reviewed articles flagged for interest to “Case 
Management,” while these filters were not available in the MEDLINE interface. After 
removing duplicate results from the two databases, the search process manually identified 
and removed publications which were focused on specific disease conditions such as 
mental or cardiac health.  
For the second literature review, on the topic of “data mining for predictive 
healthcare analytics,” SCOPUS was selected as more appropriate than MEDLINE and 
CINAHL due to its broader coverage outside biomedical disciplines (Falagas, Pitsouni, 
Malietzis, & Pappas, 2008). This second search used this query: 
 
"data mining"  
AND "clinical prediction"  
AND (LIMIT-TO(SUBJAREA,"MEDI" ) )  
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(where SUBJAREA = subject area and MEDI = medicine). The search process excluded 
publications not in the English language and restricted results to research articles, then 
manually identified and removed publications which were focused on specific disease 
conditions such as mental or cardiac health.  
 
2.3 Results of the review 
 The search of the translational literature narrowed the MEDLINE results from 54 
to 38 publications and the CINAHL results from 1,555,776 to 119 publications, for a 
combined total of 157. The search of the methodological literature narrowed the 
SCOPUS results from 225 to 70 publications. Figure 2 summarizes the results of both 
search processes. 
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Figure 2. Data flow diagram for literature searches 
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2.4 Interpretation of the review results 
The 157 studies discovered on “risk stratification in population health 
management of chronic disease” supported consensus on at least three broad findings:  
1. Managed care, preventive care, and disease management programs improve 
health outcomes. Specific evidence for this finding included reduced costs 
(Ahmed & Pearce, 2010; Ahmed, Taylor, McDaniel, & Dyer, 2012; Kruse, 
Zweig, et al, 2010; Schwartz et al, 2010), utilization (Ahmed & Pearce, 2010; 
Drozda, Libby, Keiserman, & Rundhaug, 2008; Hamar et al., 2010; Kruse, Zweig, 
et al, 2010), length of stay (Ahmed & Pearce, 2010; Ahmed, Taylor, McDaniel, & 
Dyer, 2012), and readmissions (Ahmed & Pearce, 2010; Ahmed, Taylor, 
McDaniel, & Dyer, 2012); and increased patient function and satisfaction (Ahmed 
& Pearce, 2010; Ahmed, Taylor, McDaniel, & Dyer, 2012; Bohman et al, 2011; 
Wiley et al, 2015).   
2. Health outcomes for special populations are improved when management is 
modified to fit their specific needs. This finding has been duplicated in disabled 
(Burns, 2009; Hall, Kurth, & Chapman, 2015), homeless (Levitt et al., 2013; 
McCormack, Hoffman, Wall, & Goldfrank, 2013; Patterson, Nochajski, & Wu, 
2014), minority (Eberly, Davidoff, & Miller, 2010; Smith-Gagen, Loux, Drake, & 
Perez-Stable, 2016), female (Bierman & Clancy, 2000; Kneipp et al., 2013), 
pediatric (Morris, Schettine, Roohan, & Gesten, 2011), elderly (Ahmed, Taylor, 
McDaniel, & Dyer, 2012; Black, 2011; Kwak, Kramer, Lang, & Ledger, 2013), 
and hospice (Brink & Smith, 2008) populations.   
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3. Outcomes can be improved even more when supported by risk assessment and 
predictive analytics. Despite the wide variation in risk within populations 
(Chernew, Weissert, & Hirth, 2001), health risk assessment tools (Drozda, Libby, 
Keiserman, & Rundhaug, 2008; Krist et al, 2016) and claims-based risk modeling 
(Drozda, Libby, Keiserman, & Rundhaug, 2008) are reliable predictors of 
subsequent hospital utilization. Identification, assessment, intervention are 
particularly critical for high-risk (Boult) and end-of-life (Shmueli, Messika, 
Zmora, & Oberman, 2010) patients, and even moderate adverse selection places 
managed care plans at financial risk (Zaslavsky & Buntin, 2002). 
 
In addition to this consensus, there were areas of dispute and lack of knowledge in 
the “risk stratification in population health management of chronic disease” literature, 
including these three unresolved questions:  
1. Given that managed care and disease management programs improve health 
outcomes, do they also reduce costs? Total costs and savings of care management 
have been studied in many settings including Medicaid (Greene et al., 2008), low-
income (Bohman et al., 2011) and geriatric (Ahmed & Pearce, 2010) populations, 
commercial insurance coverage (Schwartz et al., 2010), and employee-sponsored 
programs (LeCheminant & Merrill, 2012; Liu et al., 2013; Loeppke, Edington, & 
Bég, 2010; Loeppke et al., 2008). While some studies have found cost savings 
(Ahmed & Pearce, 2010; Schwartz et al., 2010) or improved workplace 
productivity (Bohman et al., 2011; LeCheminant & Merrill, 2012), others have 
not (Greene et al., 2008; Loeppke, Edington, & Bég, 2010; Loeppke et al., 2008). 
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Liu et al. (2013) found a cost increase in the first year of an employee-sponsored 
program, followed by a decrease in the following years. Greene et al. (2008), 
reviewing eleven Medicaid managed care interventions across the United States, 
found one intervention that provided a twelve-fold return on its investment, one 
with a six-fold return on investment, two others with modest returns, four with 
savings sufficient to offset their costs, and three with negative returns.    
2. How can population health management be implemented sustainably? Kruse, 
Zweig, et al. (2010) pointed out that the established US fee-for-service model 
provided no mechanism for supporting care coordination. A few studies have 
examined the impact of private versus public funding for population health 
management, with one finding improvements in costs and outcomes from retail 
medical clinics (Rohrer, Angstman, & Bartel, 2009) and others finding that for-
profit care management produced worse care (Schmuttermaier, Schmitt, King, & 
Gwynne, 2011) and worse outcomes (Decker, 2011). Other studies have 
examined the benefits of case-management interventions variously directed by 
nurse care coordinators (Kruse, Zweig, et al., 2010; Shin et al., 2010), nurses and 
physicians in collaboration (Schraeder et al., 2008), or by patients themselves 
(Laragy & Allen, 2015). Williams & Cooper (2008) examined the optimal 
caseload sizes for improved outcomes and reduced costs, and others have studied 
the impacts of innovative approaches such as employee-sponsored care 
management (Kaspin, Gorman, & Miller, 2013) and the use of online primary-
care visits (Rohrer et al., 2010). 
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3. What available data are most predictive of health outcomes and costs, and how 
can risk assessment be improved? Older investigations of this question included 
evaluations of data sources, such as administrative records (Coleman et al., 1998) 
and claims data (Zhao, Ash, Ellis, & Slaughter, 2002). More recently, engaging 
physicians in risk assessment (Springrose, Friedman, Gumnit, & Schmidt, 2010) 
has been examined as an additional source of data. Improvements have been 
documented from including the interactions of independent risk factors such as 
race and age (Sandberg et al., 2009), age and obesity (Rohrer, Takahashi, & 
Adamson, 2008), or obesity and comorbidities (Twells, Bridger, Knight, 
Alaghehbandan, & Barrett, 2012). Cucciare & O'Donohue (2006) also 
recommended rigorous statistical analysis of risk-adjustment models.  
 
The 85 studies discovered on “data mining for predictive healthcare analytics” 
supported consensus on these two findings:  
1.   Machine learning is good for big structured data but clinically interpretable 
methods (such as logistic regression) are more acceptable in clinical decision 
support than “black boxes”. Risk stratification, whether presented as risk-
prediction models (Kruppa, Ziegler, & König, 2012), clinical decision support 
(Fraccaro et al., 2015), or simple risk calculators (Mansmann, Rieger, Strahwald, 
& Crispin, 2016), can support population health management. Machine-learning 
methods can offer advantages over classical techniques (Kruppa, Ziegler, & 
König, 2012; Malley, Kruppa, Dasgupta, Malley, & Ziegler, 2012), but 
Steyerberg at al. (2012) warn that “black box” machine-learning tools (such as 
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artificial neural networks and support vector machines) that don’t produce 
interpretable rules are less useful for clinical applications.   
2.   Incremental increase in “area under the curve” (AUC) of sensitivity versus one-
minus-specificity is a good measure of a model’s discrimination, but clinical 
usefulness must always be considered in the context of pre-test probability, 
clinical significance, and the relative costs of over-diagnosis and under-
diagnosis. Although Kruppa, Ziegler, & König (2012) and Steyerberg et al. 
(2012) have offered alternatives to the AUC method of evaluation, they and 
others (Mansmann, Rieger, Strahwald, & Crispin, 2016) acknowledge that is a 
useful and widely-used standard of comparison between risk-prediction models. 
Like other evaluation methods, however, it is vulnerable to common errors in 
interpretation when considered out of clinical context (Steyerberg et al., 2012). 
 
In addition to this consensus, there were areas of dispute and lack of knowledge in 
the “data mining for predictive healthcare analytics” literature, including these two 
unresolved questions:  
1.   Are other measures of discrimination better than “area under the curve”? 
Kruppa, Ziegler, & König (2012) proposed predictiveness curves and the Brier 
score as useful alternatives to the AUC, while Steyerberg et al. (2012) proposed 
“net benefit” (the net fraction of true positives gained using the new predictor at a 
single threshold) and “net reclassification index” (the net fraction of 
reclassifications in the right direction by making decisions based on predictions 
with the marker compared to decisions without the marker). 
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2.   How can big data in healthcare be used and shared without risking patient 
privacy? Although specific policy recommendations are rare, the critical needs 
are for shared data governance and patient privacy (Collins & Wagner, 2005), 
clinican engagement, patient engagement, and shared decision making (Fraccaro 
et al., 2015), transparency and reproducibility (Ghassemi, Celi, & Stone, 2015), 
and interdisciplinary collaboration and workflow integration (Marchevsky & 
Wick, 2004). 
 
2.5 Conceptual framework for the present study 
While the study presented here will include some preliminary cost analyses, it is 
not able to answer questions about overall costs savings, even if limited to the present 
study population and time period. Neither can it answer policy and economic questions of 
sustainably implementing population health management or managing, protecting, and 
sharing research data. It will not attempt to validate newer measures of predictive 
discrimination, but will limit itself to the widely used “area under the curve” (AUC).  
However, by demonstrating simple and effective informatics strategies for 
identifying patients within a managed population who are at increased risk, this study 
does contribute to answering the third question discovered in the literature review: what 
patient attributes are really predictive of higher healthcare costs and worse healthcare 
outcomes? And, more fundamentally, what informatics strategies can be used to reliably 
and interpretably discover those attributes among the wealth of data available in 
electronic medical records? 
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CHAPTER 3.  METHODS 
 
3.1 Study population and setting 
In 2012, the Centers for Medicare and Medicaid Services awarded $13.3 million 
to the School of Medicine at the University of Missouri for LIGHT2 (Leveraging 
Information Technology to Guide Hi-Tech and Hi-Touch Care), a three year pilot 
program to examine the use of advanced health information technology and care 
coordination in a managed population. The LIGHT2 program recruited more than 10,000 
primary care patients at the University of Missouri Health System who were already 
enrolled in Medicare or Medicaid, and hired over 20 experienced registered nurses to 
manage the patients’ health care between doctor’s visits. The premise explored by 
LIGHT2 was that a combination of advanced information technology and comprehensive 
health care coordination could improve the health outcomes of Medicare and Medicaid 
beneficiaries and improve health care delivery, while lowering costs by reducing the 
number of emergency visits and hospitalizations. 
Adult primary care in the University of Missouri Health System (UMHS) is 
provided by approximately 133 primary care physicians who practice in nine regional 
clinics; the Department of Family and Community Medicine operates five local 
outpatient clinics and two in nearby communities, and the General Internal Medicine 
section of the Department of Medicine operates two local clinics. This community-based, 
primary care focus is supported by an extensive UMHS tertiary-care system of six 
hospitals and more than 50 clinics, staffed by approximately 550 university physicians. 
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3.2 Identification of the cohorts 
The LIGHT2 study enrolled all participants between early 2013 and early 2015. 
Because additional patients were enrolled after the beginning of the intervention period, 
and some patients withdrew or were otherwise lost to followup, the total number of 
patients in the study varied slightly between analyses conducted at different times. In 
addition, because some study cohorts were defined by risk characteristics that changed 
over time, the total number of patients in each cohort varied slightly between analyses 
conducted at different times. 
 
3.3 Data collection 
Diagnoses and utilization histories for all LIGHT2 patients between 1 January 
2012 and 31 December 2014 were collected retrospectively from the UMHS Health 
Analytics Library, an analytic data mart created for the LIGHT2 study to reflect the 
relevant contents of the UMHS electronic health records system. 
In order to compare costs for different years, UMHS healthcare charges were 
adjusted to 2014 dollars. Because UMHS charges were adjusted upward by 3% on April 
1 of each year during the study period, charges billed from April 1, 2013, to March 31, 
2014, were adjusted by multiplying times 1.03. Charges billed from October 1, 2012, to 
March 31, 2013, were multiplied by (1.03 x 1.03) or 1.061. 
 
3.4 Risk stratification  
 Four risk stratification tiers were defined as shown in Figure 3 (Popejoy et al., 
2015). Patients who had none of the 27 chronic conditions identified in the Chronic 
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Conditions Warehouse, or CCW (Goodman, Posner, Huang, Parekh, & Koh, 2013), 
constituted the lowest-risk or “Healthy” category (Tier 1). Patients with one or more 
chronic conditions were placed in higher tiers depending on the number of their 
outpatient clinic visits and hospital episodes during the year prior to analysis. Patients 
with five to twelve related outpatient visits or one related hospital episode in a year were 
defined as “Unstable” (Tier 3), based on the investigators’ clinical judgement. Patients 
with chronic conditions but fewer visits and episodes than “Unstable” patients were 
defined as “Stable” (Tier 2), and those with more visits or more episodes than “Unstable” 
patients were defined as “Complex” (Tier 4).  
 
Figure 3. Definitions of risk stratification tiers 
 
 
In order to visualize the longitudinal stability of the four risk tiers in the study 
population, cohorts were retrospectively identified by the risk tier of each patient as of 
January 1st, 2012. The risk tiers were then retrospectively recalculated bi-weekly for each 
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patient in the cohort over the following three years. The percentage of each cohort in each 
tier, as well as the percentages deceased or lost to followup, were calculated and 
displayed as stacked bar charts. The use of these risk tiers in guiding care coordination 
for the LIGHT2 intervention is outlined in Appendix 1. LIGHT2 care coordination 
protocol by risk stratification tier 
In order to analyze the relationships between risk tiers and inpatient utilization 
charges, the hospital charges for inpatient admissions of patients in each tier were 
summed for the fiscal years ending in 2013 and 2014. Only admissions for which the 
primary diagnosis was one of the 27 chronic conditions in the CCW were included in the 
sum of charges. For each risk tier in each fiscal year, the charges for all chronic-
condition-related hospital admissions were averaged, in total and by billing category.  
 
3.5 Cluster analysis 
 In order to refine the utilization patterns of “Complex” (Tier 4) patients, the study 
identified 343 patients in this risk tier as of October 1st, 2014 and clustered them by six 
measures from the previous year: number of outpatient visits, number of emergency visits 
that did not lead to an inpatient admission, and number of observation stays, number of 
inpatient admissions, total length of inpatient stays, and number of unplanned 
readmissions within 30 days. Change in the log-likelihood function was used as the 
distance measure (Chiu, Fang, Chen, Wang, & Jeris, 2001). The two-step procedure first 
performs a coarse clustering of the original data resulting in a large number of initial sub-
clusters, then combines sub-clusters when the distance between them decreases the log-
likelihood function.   
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Following clustering of the 343 “Complex” (Tier 4) patients into three groups, the 
study gathered descriptive statistics for patient age, race, gender, marital status, insurance 
status, and annual hospital charges; and the study measured outcomes in the previous 
year for medical diagnoses, maximum hemoglobin A1c (HbA1c), maximum systolic 
blood pressure (SBP) and diastolic blood pressure (DBP), maximum low-density 
lipoprotein cholesterol (LDL), maximum body mass index (BMI), and screening results 
for a history of falling, smoking, or hazardous alcohol use. 
 
3.6 Contrast mining 
Mining data to contrast two or more conditions, or contrast mining [20], requires 
comparison groups from comparable populations. Other data reduction techniques such 
as principal components are less than ideal for several reasons: they do not make explicit 
use of the known-groups nature of the problem, are not well suited to binary data, and 
would be computationally impractical with the large number of characteristics considered 
here. Furthermore, both principal component analysis and factor analysis aim at finding 
linear combinations of features as opposed to identifying individual features that best 
discriminate between groups.  
This application of contrast mining used multiple comparison groups in order to 
test the flexibility and robustness of the methodology under varying input conditions. 
Hospital and clinic charges were selected as the outcome of interest for this study because 
they are easily measured, continuously distributed, and can be compared comprehensibly 
between diverse patients or populations. Contrasting the 5% of patients who incurred the 
highest costs with varying subsets of the other 95% of patients tested whether this 
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contrast-mining strategy would produce widely divergent results depending on slight 
variations in the comparison group, or the whether the results would instead be robust 
and reproducible regardless of those initial conditions.  
The study excluded patients with zero healthcare system charges on the grounds 
that individuals with no recent hospital or outpatient visits may not have current medical 
histories in the healthcare system EHR. Therefore, the comparison groups comprised 
each of the lowest non-zero 5%, 10%, 20%, 30%, 40%, and 50% of fiscal year 2013 
charges. The definitions of these comparison groups are summarized in Table 1. 
 
Table 1. Comparison groups from patients with lowest non-zero prior-year charges 
  5% 10% 15% 20% 30% 40% 50% 
Lowest charge in range <- - - - - - - - - - - - - - - - - - - - $27 - - - - - - - - - - - - - - - - - - - -> 
Highest charge in range $470 $853 $1,221 $1,621 $2,646 $4,300 $6,963 
Percentage of all charges <0.1% 0.2% 0.5% 0.8% 1.8% 3.5% 6.1% 
 
Because contrast mining with the remaining 95% of patients would bias the model 
to non-high-charge utilizers, matched-size comparison groups were defined by random 
selection from each of the lowest non-zero comparison groups. Figure 4 shows the 
distribution of the excluded zero-cost patients and the lowest and highest non-zero 
charges by patient for that fiscal year. 
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Figure 4. Logarithmic distribution of fiscal year 2013 charges by patient 
 
 
  Figure 5 shows the data collected for patients in these groups, including nine 
demographic attributes: age, gender, race/ethnicity, marital status, English fluency, 
Medicaid coverage, high prior-year (fiscal year 2012) costs, body mass index (BMI), and 
history of adherence to prescription instructions. The study additionally categorized the 
3,615 ICD9 codes found for these patients into 612 disease-related groups, and the 
10,725 prescriptions into 55 higher-level therapeutic classes. All 19,014 attributes were 
collected for the selected patients at the end of fiscal year 2012, prior to the fiscal year 
2013 outcome of interest. 
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Figure 5. Data collection for contrast mining 
 
 
 In order to process contrast mining algorithms, a distributed association-rule 
mining tool suite was built on Apache Spark in the Hadoop Distributed File System 
(Shvachko, Kuang, Radia, & Chansler, 2010). Because contrast mining algorithms 
require binary values, the study transformed all attributes to true-or-false flags after 
converting continuous variables to standard categories (US Centers for Disease Control 
and Prevention, 2016). For example, each categorical variable (i.e., race/ethnicity and 
marital-status) was transformed to a set of binary values: (a) “race/ethnicity=white-non-
Hispanic or not, =Hispanic or not, =African-American or not, =Asian or not, =Native-
American or not, =other or not, =unknown or not,” and (b) “marital-status=single or not, 
=married or not, =divorced or not, =widowed or not.” Gender, a categorical variable with 
only two values in this population, was not transformed. The two clinical alert flags (i.e., 
English fluency and prescription adherence) were transformed to “normal” or 
“abnormal.” The “Apriori” algorithm (Agrawal & Srikant, 1994) was then executed with 
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a support of 0.2 (i.e., excluding attribute combinations found in less than 20% of 
patients), and the results were limited to attribute combinations that included the outcome 
of interest (fiscal year 2013 charges in the top 5% for that year).  
In the second step, the algorithm dissected the attribute combinations found 
frequently (20% or more) in high-cost patients and infrequently in low-cost patients into 
individual attributes, and treated these contrasting attributes as hypotheses to be tested 
with multiple regression. Forward selection with p < 0.05 was the entry criterion to add 
attributes to a simplified regression model for each comparison group. Interaction terms 
were not included. Because the dependent variable was expressed as a binary classifier 
(high vs. low utilization), the study used logistic regression (Cox, 1958) to construct the 
risk prediction model. Each candidate predictor generated a Variance Inflation Factor 
(VIF) resulting from the regression of that variable on the other candidate predictors. 
None of the VIF values exceed 3.8, substantially less than the standard rule of thumb that 
a VIF of 10.0 or greater signals instability in the regression coefficients (Myers, 1990). In 
addition, the study examined influence plots from the final model to see if individual 
cases exerted extreme influence on the regression coefficients, identifying no remarkable 
observations. 
The discrimination of the resulting prediction was evaluated by testing the 
predicted outcome against the actual outcome (fiscal year 2013 charges over $94,895 or 
not) for the entire study population of 9,581 patients. Discrimination was defined as the 
c-statistic, or the area under the receiver operating characteristic curve of sensitivity 
versus one-minus-specificity (Hanley & McNeil, 1982). Each comparison group (lowest 
non-zero 5%, 10%, 15%, 20%, 30%, 40%, and 50%) was contrast-mined independently 
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against the 5% of patients with highest fiscal year 2013 charges, and the resulting models 
were tested independently. The attributes common to all these models also were used to 
derive a combined model using all fiscal year 2013 observations, which was also tested 
independently. 
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CHAPTER 4.  RESULTS 
 
4.1 Characteristics of study participants 
 As shown in Figure 6, 42% of LIGHT2 study participants were younger than 65 
years, with ages distributed approximately evenly between 20 and 64 years. The ages of 
the remaining participants at enrollment tapered from a peak of more than 300 
participants of age 65 years (more than 3% of the entire study population) to very few 
with ages over 100 years. At all ages, females outnumbered males in the study population 
by about 3:2. The peak at age 65 years is explained by the study inclusion criteria of 
Medicare and/or Medicaid enrollment, because relatively few working-age US adults are 
enrolled in Medicaid (Coleman A. , 2014) or Medicare (Centers for Medicare & 
Medicaid Services, 2014), but most retirement-age US adults are enrolled in Medicare 
(Centers for Medicare & Medicaid Services, 2014). 
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Figure 6. Number of LIGHT2 patients by age and gender 
 
 
 Figure 7 shows the prevalence of the 27 CCW-defined chronic diseases 
(Goodman, Posner, Huang, Parekh, & Koh, 2013) in the study population. These ranged 
from hypertension, with a prevalence of 41%, to acute myocardial infarction, which was 
not found in the study population. 
 
 29 
  
Figure 7. Prevalence of monitored chronic conditions in the LIGHT2 population 
 
 
4.2 Validation of the risk stratification tiers 
Of 9,581 patients in the tier validation cohort on October 1, 2013, 63% (n = 
6,014) were in Tier 2 while Tiers 1 and 3 comprised 16% each (n = 1,554 for Tier 1; n = 
1,555 for Tier 3), with the remaining 5% (n = 458) in Tier 4. More than three-fourths of 
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the Tier 1 enrollees were younger than 65, but fewer than half of the enrollees in the other 
tiers were under 65. Figure 8 shows this distribution of the risk stratification tiers. 
 
Figure 8. Distribution of patients by age and risk tier 
 
 
 Figure 9 shows the mean number of hospital episodes by type, within each tier, 
during the 12 months following cohort formation. For all episode types, the overall 
differences remained significant (p < 0.001). “Complex” (Tier 4) patients had 
significantly more episodes on average than “Unstable” (Tier 3) patients; they, in turn, 
had significantly more episodes than “Stable” (Tier 2) or “Healthy” (Tier 1) patients (p < 
0.001 for all comparisons). There were no significant differences between Tier 1 and Tier 
2 emergency episodes (p = 0.279), but the numbers of observation and inpatient episodes 
were significantly different between these two tiers (p < 0.001 for each type). For all 
tiers, the median number of episodes of all types was zero. 
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Figure 9. 2014 healthcare episodes by visit type within 2013 risk tier 
 
 
Figure 10 shows the mean and total healthcare charges by tier during the 12 
months after cohort formation. “Complex” and “Unstable” patients (Tiers 3 and 4), 
comprising 21% of the total population, accounted for 43% of total healthcare charges. 
Overall differences were significant (p < 0.001). “Complex” (Tier 4) patients had 
significantly higher charges on average than “Unstable” (Tier 3) patients, which had 
significantly higher charges than “Stable” (Tier 2) patients; and these in turn where 
significantly higher than for “Healthy” (Tier 1) patients (p < 0.001 for all comparisons). 
Median charges in each tier (respectively $0, $2,343, $8,662, and $20,412) were likewise 
significantly different overall (p < 0.001) and higher in the higher tiers (p < 0.001 for all 
comparisons). 
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Figure 10. 2014 healthcare charges by 2013 risk tier 
 
 
The association of higher 2014 utilization and costs with risk tiers based on 2013 
utilization supported a hypothesis that risk stratification for individuals would be 
relatively stable over time. However, the predominance of over-65 patients in all but the 
lowest risk tier, and the prevalence of chronic conditions in study population, led to a 
hypothesis that this aging and well insured population would gradually rise in risk of 
healthcare utilization over the course of a few years. The results of the longitudinal tier 
movement studies were used to test these secondary hypotheses. 
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4.3 Movement between risk stratification tiers 
“Healthy” (Tier 1) patients had a 56% chance of staying in the same risk tier, and 
a 27% chance of moving to the next higher tier, as shown in Figure 11. “Stable” (Tier 2) 
patients, shown in 
Figure 12, had a 68% chance of staying in in the same risk tier, and a 13% chance 
of moving to the next higher tier. “Unstable” (Tier 3) patients had a 48% chance of 
moving to the next lower tier, and a 26% chance of staying in the same risk tier, as shown 
in Figure 13. And as shown in Figure 14, “Complex” (Tier 4) patients had a 37% chance 
of moving to a much lower risk tier, a 25% chance of moving to the next lower tier, and 
an 18% chance of remaining in the same tier. 
 
Figure 11. Movement of a “Healthy” (Tier 1) cohort in the following three years 
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Figure 12. Movement of a “Stable” (Tier 2) cohort in the following three years 
 
 
Figure 13. Movement of an “Unstable” (Tier 3) cohort in the following three years 
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Figure 14. Movement of a “Complex” (Tier 4) cohort in the following three years 
 
 
As shown in Figure 11 through Figure 14 (above), the rate of death increased 
steadily in higher risk tiers, at 1%, 4%, 7%, and 9% respectively; and the loss to followup 
was 12%, 9%, 10%, and 11% respectively. 
 Although risk tiers based on chronic disease diagnoses and recent healthcare 
utilization were predictive of healthcare utilization and charges in a managed population, 
patients in this population were not likely to rise in risk over the course of the study as 
expected. Instead, patients in lower risk tiers (“Healthy” and “Stable” patients) at the 
beginning of the study period were most likely to remain in lower risk tiers, and those in 
higher initial risk tiers (“Unstable” and “Complex” patients) were most likely to move to 
lower risk tiers. In a time frame of three years, this return to stability was a more 
important influence on healthcare utilization than risk or aging. Because these unexpected 
findings highlighted the fact that the correlation of risk tiers with specific high-cost 
outcomes was unknown, more detailed analyses were performed to test the hypothesis 
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that similar utilization episodes for higher-risk patients were not only more frequent (as 
required by the definitions of the risk tiers) but also more expensive. 
 
4.4 Inpatient costs by risk stratification tier 
Analysis of charges by charges by risk tier focused on inpatient admissions 
because these episodes are more than 20 times as costly as emergency visits and more 
than 60 times as costly as outpatient visits, as illustrated in Figure 15.   
 
Figure 15. Average fiscal 2013 charges per utilization episode by episode type 
 
 
In both fiscal years ending in 2013 and 2014, average charges for chronic-
condition-related inpatient admissions of “Complex” (Tier 4) patients were near the 
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lowest for all risk tiers, at US $10,046 and $10,123 for the two years, as shown in Table 
2.  
 
Table 2. Average charges per admission by category within risk tier, US$ 
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Total 
Tier 1 
2013 1,004 626 544 460 3,808 374 603 236 173 8 324 8,162 
2014 833 623 502 150 2,671 428 330 118 266 4 1,241 7,164 
Tier 2 
2013 1,476 914 905 583 3,863 747 2,382 407 307 15 343 11,954 
2014 1,769 1,075 1,185 869 5,144 839 2,747 420 270 12 505 14,836 
Tier 3 
2013 1,533 1,063 1,110 818 4,919 755 2,468 387 267 14 299 13,633 
2014 1,539 944 862 739 4,503 712 2,183 323 282 18 313 12,423 
Tier 4 
2013 764 575 1,076 754 4,394 854 615 379 323 27 285 10,046 
2014 856 472 881 665 4,468 909 937 336 357 21 222 10,123 
 
The only lower average charges were for “Healthy” (Tier 1) patients at $8,162 and 
$7,164. The highest average charges were for “Stable” (Tier 2) patients at $11,954 and 
$14,835, and “Unstable” (Tier 3) patients at $13,633 and $12,423, as shown in  
Table 2 (above) and Figure 16. 
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Figure 16. Average charges per admission, US$ 
 
 
 
Table 2 (above) and Figure 17 subtotal these charges by thirteen billing 
categories. In all risk tiers for both fiscal years, nursing is the largest single billing 
category. However, the difference in average nursing charges for “Complex” patients 
($4,431) and Tiers 2 and 3 patients ($4,605 combined average) is only 4%. Charges in the 
implants, surgery, and supplies billing categories accounted for 93% of the difference 
between “Complex” patient charges and charges for “Stable” and “Unstable” patients, as 
shown in Figure 17. 
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Figure 17. Average charges per admission by category, US$ 
 
 
 Initial validation of the tier definitions showed that “Unstable” (Tier 3) and 
“Complex” (Tier 4) risk stratifications were associated with significantly higher 
utilization, but detailed longitudinal and cost analyses disproved the study’s initial 
assumptions that high risk would persist or rise over time and lead to more expensive 
utilization episodes. In order to resolve these unexpected findings, more sophisticated 
data science techniques were used to characterize the “Complex” patients, including 
cluster analysis and contrast mining. 
 
4.5 Cluster analysis of high-risk patients 
 Clustering of the 343 patients with “Complex” (Tier 4) utilization histories found 
three distinct patterns, as shown in Table 3: frequent outpatient visits for 59% of the 
group, frequent inpatient admissions for another 31%, and frequent utilization of all types 
except outpatient visits for the remaining 10% of “Super-Users”. 
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Table 3. Cluster analysis of “Complex” (Tier 4) patients by visit count and length 
 
Average number of visits by type 
(or Length of stay in days) 
All Tier 4 
n = 343 
Cluster 1 
n = 203 
(59%) 
Cluster 2 
n = 106 
(31%) 
Cluster 3 
n = 34 
(10%) 
Outpatient visits 8.76 10.75 5.67 6.44 
Emergency visits 0.62 0.61 0.24 1.82 
Observation stays 0.56 0.58 1.17 1.71 
Inpatient admissions 1.12 0.50 1.94 2.26 
(Inpatient length of stay, days) 8.70 3.28 15.55 19.74 
Unplanned 30-day readmissions 0.48 0.05 0.61 2.56 
 
Average annual healthcare charges varied more than threefold between the three 
clusters within “Complex” (Tier 4) patients, from $69,893 for the “Outpatient” cluster to 
$163,700 for the “Inpatient” cluster and $229,037 for the “Super-User” cluster, as shown 
in Figure 18.  
 
Figure 18. Average annual charges by episode type within cluster 
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As shown in Figure 19, “Super-Users” were more likely than other “Complex” 
(Tier 4) patients to have diagnoses of diabetes or asthma, but less likely to have arthritis, 
acquired hypothyroidism, atrial fibrillation, or osteoporosis. 
 
Figure 19. Prevalence of chronic conditions by “Complex” (Tier 4) cluster 
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 As shown in Table 4, “Super-Users” were more likely than other “Complex” (Tier 
4) patients to be have Medicaid coverage, have poorly controlled blood glucose (HbA1c  
> 9%), have positive histories for falling, smoking, or hazardous drinking, or have serious 
mental illness (schizophrenia, major depression, or bipolar depression). The rate of 
diastolic hypertension (DBP ≥ 90 mmHg) was slightly but significantly (p < 0.05) lower 
in the “Outpatient” cluster than the “Inpatient” cluster, but neither was different from the 
“Super-User” cluster in this measure; and the rate of systolic hypertension (SBP ≥ 140 
mmHg) was not different between any of the three clusters. 
 Gender and race were not significantly (p < 0.05) different between the three 
clusters, nor were hyperlipidemia (LDL ≥ 100 mg/dL), obesity (BMI ≥ 30), or multi-
morbidity (number of chronic conditions). “Super-Users” were significantly younger and 
more likely to be single than other “Complex” (Tier 4) patients. This may have been 
confounded by the higher rate of Medicaid coverage among “Super-Users,” because 
LIGHT2 eligibility required either Medicaid coverage or Medicare coverage (with a 
typical age of 65 or older). 
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Table 4. Selected attributes of “Complex” (Tier 4) patients by cluster 
 
Attribute 
All Tier 4 
patients 
“Outpatient” 
users 
“Inpatient” 
users 
“Super-
Users” 
p-
value 
Demographic Attributes 
Age (years) 66.7 + 17  68.0 + 16   69.5 + 16 50.0 + 18 0.000 
Marital Status:     .020 
    Married 147 (43%)    96 (47%)  39 (37%) 12 (35%)  
    Divorced/Separated 62 (18%)   35 (17%)  24 (23%)  3   (9%)  
    Single 68 (20%)   35 (17%) 19 (18%) 14 (41%)  
    Widowed 66 (19%)   37 (18%) 24 (23%)   5 (15%)  
Medicaid  97 (28%) 47 (23%) 32 (30%) 18 (53%) 0.001 
Health Outcomes 
HbA1c  > 9%  41 (22%)                 21 (19%) 9 (16%) 11 (50%) 0.003 
SBP ≥ 140 mmHg 315 (96%) 182 (95%) 100 (98%) 33 (97%) 0.184 
DBP ≥ 90 mmHg 284 (87%) 156 (81%) 97 (94%) 31 (94%) 0.003 
LDL ≥ 100 mg/dL 74 (22%) 44 (38%) 24 (36%) 6 (31%) 0.864 
BMI ≥ 30  196 (61%) 112 (61%) 61 (60%) 23 (70%) 0.580 
Chronic conditions 6.2 + 2.7 6.1 + 2.6 6.2 + 2.6 6.3 + 3.5 0.921 
Mental Health and Behavior  
Fall history  139 (41%) 57 (28%) 62 (59%) 20 (59%) 0.000 
Smoking  95 (28%) 46 (23%) 30 (29%) 19 (58%) 0.000 
Hazardous drinking  33 (11%) 11   (6%) 14 (16%) 8 (28%) 0.001 
Serious mental illness  93 (27%) 46 (23%) 32 (30%) 15 (44%) 0.023 
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 While cluster analysis was successful at identifying important sub-groups within 
the high-cost patients, it was not appropriate for characterizing the differences between 
high-cost and low-cost patients, which were defined deductively by the study’s original 
risk-stratification schema. Contrast mining was selected as the most effective strategy for 
this final step. 
 
4.6 Contrast mining of high-cost vs. low-cost patients 
Contrast mining of 19,014 clinical attributes from the first year of electronic 
medical records (EMR) data for 479 high-cost patients and comparison groups with low-
cost patients (ranging from the lowest 5% to the lowest 50%) identified 5,188 attribute 
combinations frequently found (support of 20% or more) in patients with high costs in the 
second year, but infrequently in other patients. A sample of ten of these combinations is 
illustrated in Table 5.  
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Table 5. Ten (out of 5,188) combinations frequently associated with high costs 
Attribute Combination Support 
Narcotic analgesics, Analgesics, Platelet aggregation inhibitors 0.21 
Anti-hyperlipidemic agents, Analgesics, HMG CoA reductase inhibitors 0.39 
Antidepressants, ICD9=311 (Depressive disorder), Antihistamines 0.20 
Beta-adrenergic blocking agents, Cardioselective beta blockers, Nutritional 
products  
0.29 
Narcotic analgesics, Respiratory agents, Nutritional products 0.20 
Race=White, Salicylates, Antiplatelet agents, Platelet aggregation inhibitors, 
Age=65to84  
0.25 
Antiplatelet agents, Analgesics, Beta-adrenergic blocking agents, Platelet 
aggregation inhibitors 
0.33 
Vitamins, Gastrointestinal agents, Salicylates, Nutritional products, 
Antiplatelet agents 
0.20 
Narcotic analgesics, Anxiolytics/sedatives/hypnotics 0.25 
Narcotic/analgesic combinations, Gastrointestinal agents, Laxatives 0.23 
 
Not all combinations were infrequent in all comparison groups, but at least 5,178 
of the 5,188 contrasted in all seven analyses. These 5,188 contrasting combinations were 
made up of 67 unique attributes, listed in Appendix 1. LIGHT2 care coordination 
protocol by risk stratification tier 
Coordination Domain Tier 1 Tier 2 Tier 3 Tier 4 
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Negotiate responsibility - - X X 
Communication - - X X 
Facilitate transitions - - - X 
Assess needs and goals - - X X 
Create a proactive plan of care - - X X 
Monitor and respond to change  - - - X 
Support self-management - - X X 
Link to community resources - - - X 
Align resources with needs - - - X 
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Appendix 2. Individual attributes found in combinations associated with high 
costsLogistic regression of the 67 contrasting attributes found eleven attributes to be 
significantly (p<0.05) associated with high costs. This final regression model is detailed 
in Table 6. 
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Table 6. Final model of attributes associated with high costs 
Attribute Coef-
ficient 
p-value Odds 
ratio 
95% Confidence 
limits 
Diagnoses 
ICD9=311, Depressive disorder  0.5568 <0.0001 1.707 1.343 2.168 
ICD9=401.9, Unspecified 
essential hypertension 
0.3967 0.0007 1.423 1.128 1.795 
ICD9=414, Ischemic heart 
disease 
0.5939 <0.0001 1.828 1.386 2.411 
ICD9=715, Osteoarthrosis  1.0479 <0.0001 2.769 2.192 3.499 
Demographic Attribute 
Obesity (BMI ≥ 30) 2.3520 <0.0001 9.496 7.530 11.976 
Prescription Types 
 
Anti-infectives 0.4136 0.0060 1.504 1.117 2.025 
Benzodiazepines 0.2975 0.0139 1.307 1.026 1.665 
Beta-adrenergic blocking agents 0.2832 0.0148 1.314 1.047 1.649 
Quinolones 0.4916 0.0087 1.674 1.158 2.421 
Respiratory agents 0.3030 0.0063 1.340 1.076 1.668 
Selective serotonin reuptake 
inhibitor (SSRI) antidepressants 
-0.4062 0.0019 0.655 0.506 0.847 
* Intercept = -4.2585 with p < 0.0001 
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As shown in Figure 20, the c-statistic of the resulting model was 0.8436, with a 
95% confidence interval of (0.8227, 0.8645). By assuming sensitivity and specificity 
errors to be equally important, an optimal threshold for the model was calculated to 
minimize the distance to the upper left corner of the receiver operating characteristic 
graph. 
 
Figure 20. Receiver operating characteristic curve for the final model  
 
 
This distance from the upper left corner of the graph to the nearest point of the 
curve was calculated as  
 
√(1 − 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦)2 + (1 − 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦)2   
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(Zhou, Obuchowski, & McClish, 2002) and tuning the model to this threshold produced a 
sensitivity of 0.770, a specificity of 0.812, a positive predictive value of 0.202, and a 
negative predictive value of 0.983. While the positive predictive value of 20% and 
negative predictive value of 98% appear low and high, respectively, they are reasonably 
useful given a population in which only 5% of patients are truly positive for high cost, 
and 95% of patients are negative. For example, a positive predictive value of 20% would 
result in five patients receiving the intervention of care management for every patient 
actually destined to incur high costs without intervention. This over-treatment penalty 
may be reasonable because care management is both extremely safe and cost-effective, 
and because the 98% negative predictive value of the model would direct population 
health managers away from nearly all patients who will not incur the highest 5% of costs 
without the intervention. These examples demonstrate the utility of mining the rich data 
available in the EMR to predict the small number of patients who will incur the majority 
of healthcare expenses, which support population health managers in focusing preventive 
and longitudinal care more effectively. 
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CHAPTER 5.  DISCUSSION 
 
5.1 Primary findings 
The most important results of these analyses point to the effectiveness of these 
informatics strategies in identifying patients at risk of high cost and high utilization. The 
two highest risk stratification tiers, “Unstable” (Tier 3) and “Complex” (Tier 4) 
comprised only 21% of patients but accounted for 43% of prospective charges. Within 
“Complex” (Tier 4) patients, cluster analysis found a small group, the most expensive 5% 
of the most expensive 10%, were nearly twice as costly per patient as “Complex” patients 
on average. Finally, combining contrast mining with logistic regression predicted the 
most expensive 5% of patients with 84% accuracy. All the strategies used in this study, 
from the simplest to the most sophisticated, produced useful insights. 
Risk stratification tiers, based on healthcare utilization and charges over the 
previous twelve months, provided highly useful information about what is likely to occur 
going forward. This finding confirms the expectation that past utilization is a good 
predictor of future utilization. When viewed through a population health lens, the 
extraction of readily available retrospective data can provide care coordinators with 
useful information that allows them to focus their efforts on those patients who care 
needs are most expensive, and who may require more intensive management. The risk 
stratification tiers examined in this study were defined on the basis of diagnoses that are 
included in the Chronic Conditions Data Warehouse (Goodman, Posner, Huang, Parekh, 
& Koh, 2013) and on utilization categories that are in general use in healthcare systems. 
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Because these are easily reproducible, the LIGHT2 risk stratification framework is 
potentially applicable to other healthcare systems. 
Clustering of the 343 patients with “Complex” (Tier 4) utilization histories found 
three distinct patterns: frequent outpatient visits for 59% of the group, frequent inpatient 
admissions for another 31%, and frequent utilization of all types for the remaining 10% 
of “Super-Users”. Average annual healthcare charges varied more than threefold between 
the three clusters within Tier 4, from $69,893 for the “Outpatient” cluster to $163,700 for 
the “Inpatient” cluster and $229,037 for the “Super-User” cluster. 
The last strategy, a novel two-step combination of EMR data mining with 
multiple logistic regression, yielded a manageably small number of clinical attributes 
which accurately predicted the 5% of patients who incurred nearly 50% of healthcare 
expenses. The model presented here has the virtue of simplicity and interpretability while 
still achieving an accuracy of 84%, higher than the value of 70% reported in comparable 
models (O’Caoimha et al., 2015).  
 
5.2 Secondary findings 
Initial validation of the risk stratification tiers discovered that there was no 
difference in mean number of emergency department episodes between “Healthy” (Tier 
1) and “Stable” (Tier 2) patients; and the differences in outpatient and inpatient visits 
between these groups were relatively small. Because the cost and utilization patterns of 
patients in these risk tiers are not notably different, it may be that time and resources 
devoted to keeping “Stable” (Tier 2) patients from evolving into the much more costly 
“Unstable” (Tier 3) utilization pattern would be a useful care coordination strategy. 
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In a related finding, but contrary to the study’s secondary hypothesis that the 
members of an aging and well insured population would gradually rise in risk of 
healthcare utilization over the course of three years, patients in lower risk tiers (“Healthy” 
and “Stable” patients) at the beginning of the study period were most likely to remain in 
lower risk tiers after three years. Those in higher initial risk tiers (“Unstable” and 
“Complex” patients) were most likely to move to lower risk tiers after three years. The 
consistently higher death rate in higher risk tier cohorts, however, provides an additional 
validation of the predictive utility of the risk tiers. 
Another finding that reversed a secondary study hypothesis was that charges for 
admissions of “Complex” patients were less expensive on average than those for “Stable” 
(33% higher overall) and “Unstable” (30% higher overall) patients. Most of the 
difference seems to be explained by “Complex” patients getting less surgery and fewer 
implants than “Stable” and “Unstable” patients. This may be because complex-care 
patients were often less appropriate candidates for elective surgery. While the primary 
findings confirm that using risk stratification to help predict future healthcare utilization 
and charges is a valuable emerging technique in practice management, these unexpected 
secondary findings demonstrate that costs and utilization must be understood in some 
detail in order to discover the knowledge hidden in the data. 
Patients in the “Super-Users” cluster of the “Complex” (Tier 4) patients, the 
costliest 10% of the costliest 5%, had significantly worse mental health, poverty, and 
behavior risks. This group was more likely than any other to have diabetes and asthma, 
but less likely to have arthritis and osteoporosis, acquired hypothyroidism, and atrial 
fibrillation. These protective findings may be related to the younger average age of the 
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group, which may be a consequence of a greater proportion of Medicaid beneficiaries in 
this cluster. 
All of the four diagnoses identified by contrast mining are among the ten most 
expensive medical conditions in the U.S. in 2013 (US Agency for Healthcare Research 
and Quality, 2016): (a) ischemic heart disease (second most expensive), (b) depression 
(third), (c) osteoarthrosis (fifth), and (d) hypertension (eighth). Of the prescription types 
found to be associated with high utilization, beta-adrenergic blocking agents may be 
indicative of ischemic heart disease (second most expensive); benzodiazepines may be 
indicative of depression (third), and respiratory agents may be indicative of chronic 
obstructive pulmonary disease (sixth). The partial congruence of the sample model with 
the medical conditions known to be most expensive validates the generalizability of these 
findings, while demonstrating the potential for other, novel discoveries (i.e., a nearly ten-
fold increase in the odds of high costs associated with obesity, increased risks associated 
with anti-infectives in general and quinolones specifically, and risk reduction associated 
with SSRI antidepressants). 
 
5.3 Implications of study findings  
All these findings provide meaningful answers to the question that arose from a 
review of the literature, “What predicts healthcare utilization and how can we improve 
prediction?” From deductive definitions of risk stratification tiers, the simplest and most 
direct approach, it emerged that past utilization is a powerful predictor of future 
utilization, despite the tendency of sick patients to return to their baseline health. More 
detailed analyses of costs and utilization identified important sub-groups within the most 
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complex and expensive patients, and discovered distinct and sometimes paradoxical 
patterns of utilization. Applying complex algorithms to mine the deep wealth of EMR 
data on patients found even more predictors, some confirmatory and some unexpected. 
One important design limitation that affects all analyses here is that data were 
collected from a single healthcare system, and some utilization of other providers may be 
missing. This could affect both the risk stratification of patients and the number and cost 
of their admissions after stratification. Another limitation resulting from the enrollment of 
all eligible patients during the study period is that no control group was formulated for 
direct testing of the LIGHT2 treatment effect. The opportunity to compare outcomes in a 
control group would have enabled this study to examine the effects of the LIGHT2 
intervention on patient risks and detect confounding variables.  
Several study findings pointed to the effects of socioeconomic factors such as 
Medicaid eligibility, but detailed analysis of health disparities was impossible using the 
data collected here. The use of charges as a proxy for costs limited precision of the 
financial analyses, particularly because nursing charges are calculated as fixed overhead 
for patient care. The finding that nearly 3% of the study population did move from higher 
tiers to “Healthy” (Tier 1) may reflect an error in data representation, because this 
category was defined as an absence of chronic conditions. Finally, the study sample 
included only adults who received Medicare or Medicaid services in central Missouri, 
which may limit the generalizability of these findings to the wider US and global 
populations. Data from additional years and expanded data sources would refine these 
conclusions, and these analysis should be validated by replication in other populations.  
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The most important directions for future development of this research are the use 
of Medicare and Medicaid claims data for more complete collection of utilization and 
cost histories, and the analysis of additional data sources for social and geospatial 
determinants. The finding that obesity drastically increased the odds of high healthcare 
utilization should be examined further by correlating the co-morbidities of obesity with 
utilization patterns. The formulation of a comparable control group, with patients of 
similar risk propensity in a similar setting, would allow important analyses of the effect 
of the overall LIGHT2 intervention on patient health outcomes, care delivery, and costs. 
This experimental design might also be structured to detect the effects of payer models on 
patient risk and calculate pre-test likelihoods for more accurate risk prediction. In 
addition, hidden Markov models may be useful in understanding the tiers or “states” 
though which individual patients move to result in the “net” tier counts presented here, 
and more detailed billing data are needed to confirm the interactions of surgeries, 
implants, and supply costs in “Complex” (Tier 4) admission costs. Cluster analysis and 
contrast mining, which have been applied successfully to the “Complex” (Tier 4) sub-
population, should also be applied to patients in all risk tiers and clustering analyses 
should be conducted on contrast-mining results. These methods and sequence mining 
strategies are needed to find the characteristics of patients in each tier that move to lower 
or higher tiers, as well as those who remain in their initial tiers.   
 
5.4 Contributions to informatics 
This study used accessible EMR data to create simple and effective risk 
stratification tiers, and strategically applied advanced data-mining and statistical 
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methodologies to characterize and predict healthcare utilization patterns in finer detail. 
Because “black box” machine-learning algorithms were excluded from the methodology, 
the results were clinically interpretable and could support clinical decision support. The 
study also integrated simple data visualization and cost analyses to improve the use of 
predictive analytics in managed care populations. 
The coefficients of the final regression model can be used to calculate a relative 
score for all patients in a population (see Table 6). For this model, possible scores would 
range from a minimum of -4.6647, for a patient with SSRI antidepressants (coefficient = -
0.4062 added to the intercept of -4.2585) and no other predictors, to a maximum of 
+2.4777, for a patient with all predictors except SSRI antidepressants.  This can be 
normalized to an index of 0 to 100 using this formula: 
 
𝐼𝑛𝑑𝑒𝑥 = (𝐼𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 − 𝑀𝑖𝑛 +  ∑ 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑛 ∙ 𝑝𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑜𝑓 𝐴𝑡𝑡𝑟𝑖𝑏𝑢𝑡𝑒𝑛
𝑛
1 )
100
(𝑀𝑎𝑥−𝑀𝑖𝑛)
  
 
(Gelman & Hill, 2007) where “Max” is the maximum possible score generated by the 
given model (in this case, 2.4777) and “Min” is the minimum possible score (in this case, 
-4.6647). This index gives an approximate “risk” of high utilization in the upcoming year, 
and patient interventions could be prioritized using this relative risk. Alternatively, 
clinical alerts could be triggered for patients with indices exceeding a given threshold. By 
adjusting the threshold of the scoring system, the sensitivity and specificity of the model 
could be tuned to identify only as many high-risk patients as can be managed. However, 
because population health management is a low-risk and relatively low-cost intervention, 
clinical use may benefit from greater sensitivity even at the price of lower specificity. 
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The results of this study support the hypothesis that clinically interpretable 
machine-learning algorithms, combined with simpler data analytic techniques where 
appropriate, can improve risk stratification in population health management of chronic 
disease. By validating a simple and reproducible risk stratification system, demonstrating 
longitudinal changes in risk stratification, and characterizing the differences between 
high-risk and low-risk patients in clinically interpretable terms, these informatics 
strategies have the potential to support population health managers in understanding and 
predicting the healthcare needs of their patients. 
 
5.5 Conclusions 
A combination of simple and sophisticated strategies in health informatics was 
able to identify patients within a managed population at risk for higher healthcare costs, 
demonstrate longitudinal changes in risk stratification, and characterize detailed 
differences between high-risk and low-risk patients. By producing clinically interpretable 
rules to predict the small number of patients who will incur the majority of healthcare 
expenses, these methods can support population health managers in focusing preventive 
and longitudinal care more effectively. These models, and similar models developed by 
integrating diverse informatics strategies, could be used by population health managers to 
further the “Triple Aim” of better health outcomes, better healthcare delivery, and lower 
costs (Berwick, Nolan, & Whittington, 2008). 
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  APPENDICES 
Appendix 1. LIGHT2 care coordination protocol by risk stratification tier 
Coordination Domain Tier 1 Tier 2 Tier 3 Tier 4 
Negotiate responsibility - - X X 
Communication - - X X 
Facilitate transitions - - - X 
Assess needs and goals - - X X 
Create a proactive plan of care - - X X 
Monitor and respond to change  - - - X 
Support self-management - - X X 
Link to community resources - - - X 
Align resources with needs - - - X 
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Appendix 2. Individual attributes found in combinations associated with high costs 
Age = 25 to 44 Antiarrhythmic agents 
Age = 45 to 64 Anticonvulsants 
Age = 65 to 84 Antidepressants 
Race/ethnicity = White/non-Hispanic Antidiabetic agents 
Female Antiemetic anti-vertigo agents 
Male Antihistamines 
Obesity Anti-hyperlipidemic agents 
Taking Rx as prescribed Anti-infectives 
Taking Rx not as prescribed Antiplatelet agents 
Medicaid Antipsychotics 
Prior high cost Anxiolytics, sedatives and hypnotics 
ICD9 = 250 (Diabetes mellitus)  Benzodiazepine anticonvulsants 
ICD9 = 272.4 (Hyperlipidemia) Benzodiazepines 
ICD9 = 311 (Depressive disorder) Beta-adrenergic blocking agents 
ICD9 = 401.1 (Benign essential  Bronchodilators 
hypertension) Calcium channel blocking agents 
ICD9 = 401.9 (Unspecified essential Cardioselective beta blockers 
hypertension) Cardiovascular agents 
ICD9 = 414 (Ischemic heart disease) Dermatological agents 
ICD9 = 715 (Osteoarthrosis) Diuretics 
Analgesics Gamma-aminobutyric acid analogs 
Angiotensin converting enzyme inhibitors Gastrointestinal agents 
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HMG CoA reductase inhibitors Nutraceutical products 
Hormones/hormone modifiers Nutritional products 
Iron products Platelet aggregation inhibitors 
Laxatives Proton pump inhibitors 
Minerals and electrolytes Quinolones 
Miscellaneous analgesics Respiratory agents 
Miscellaneous anxiolytics, sedatives and Salicylates 
hypnotics Skeletal muscle relaxants 
Muscle relaxants SSRI antidepressants 
Narcotic/analgesic combinations Thiazide and thiazide like diuretics 
Narcotic analgesics Vitamin and mineral combinations 
Nonsteroidal anti-inflammatory agents Vitamins 
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